FGF19 and hepatoblastoma: These cholangiocyte-like cells are surrounded by embryonal hepatoblastoma cells, characterized by intermediate levels of WNT/b-catenin signaling, a high proliferation index (Ki67), and high expression of KLB, a hepatocyte transmembrane protein that plays a crucial role as a co-receptor for FGF19.